Global Endocrine System Drugs Market Research Report 2023

Report ID: 1914613 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Endocrine System Drugs Market Overview
    1.1 Product Overview and Scope of Endocrine System Drugs
    1.2 Endocrine System Drugs Segment by Type
        1.2.1 Global Endocrine System Drugs Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Diabetes Drug
        1.2.3 Human Growth Hormones
        1.2.4 Thyroid Hormone Disorder Drugs
        1.2.5 Others
    1.3 Endocrine System Drugs Segment by Application
        1.3.1 Global Endocrine System Drugs Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Medical Center
        1.3.5 Others
    1.4 Global Endocrine System Drugs Market Size Estimates and Forecasts
        1.4.1 Global Endocrine System Drugs Revenue 2017-2028
        1.4.2 Global Endocrine System Drugs Sales 2017-2028
        1.4.3 Endocrine System Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Endocrine System Drugs Market Competition by Manufacturers
    2.1 Global Endocrine System Drugs Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Endocrine System Drugs Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Endocrine System Drugs Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Endocrine System Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Endocrine System Drugs Market Competitive Situation and Trends
        2.5.1 Endocrine System Drugs Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Endocrine System Drugs Players Market Share by Revenue
        2.5.3 Global Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Endocrine System Drugs Retrospective Market Scenario by Region
    3.1 Global Endocrine System Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Endocrine System Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Endocrine System Drugs Market Facts & Figures by Country
        3.3.1 North America Endocrine System Drugs Sales by Country
        3.3.2 North America Endocrine System Drugs Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Endocrine System Drugs Market Facts & Figures by Country
        3.4.1 Europe Endocrine System Drugs Sales by Country
        3.4.2 Europe Endocrine System Drugs Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Endocrine System Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Endocrine System Drugs Sales by Region
        3.5.2 Asia Pacific Endocrine System Drugs Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Endocrine System Drugs Market Facts & Figures by Country
        3.6.1 Latin America Endocrine System Drugs Sales by Country
        3.6.2 Latin America Endocrine System Drugs Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Endocrine System Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Endocrine System Drugs Sales by Country
        3.7.2 Middle East and Africa Endocrine System Drugs Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Endocrine System Drugs Historic Market Analysis by Type
    4.1 Global Endocrine System Drugs Sales Market Share by Type (2017-2022)
    4.2 Global Endocrine System Drugs Revenue Market Share by Type (2017-2022)
    4.3 Global Endocrine System Drugs Price by Type (2017-2022)
5 Global Endocrine System Drugs Historic Market Analysis by Application
    5.1 Global Endocrine System Drugs Sales Market Share by Application (2017-2022)
    5.2 Global Endocrine System Drugs Revenue Market Share by Application (2017-2022)
    5.3 Global Endocrine System Drugs Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Novo Nordisk
        6.1.1 Novo Nordisk Corporation Information
        6.1.2 Novo Nordisk Description and Business Overview
        6.1.3 Novo Nordisk Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Novo Nordisk Endocrine System Drugs Product Portfolio
        6.1.5 Novo Nordisk Recent Developments/Updates
    6.2 Sanofi
        6.2.1 Sanofi Corporation Information
        6.2.2 Sanofi Description and Business Overview
        6.2.3 Sanofi Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Sanofi Endocrine System Drugs Product Portfolio
        6.2.5 Sanofi Recent Developments/Updates
    6.3 Merck
        6.3.1 Merck Corporation Information
        6.3.2 Merck Description and Business Overview
        6.3.3 Merck Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Merck Endocrine System Drugs Product Portfolio
        6.3.5 Merck Recent Developments/Updates
    6.4 Eli Lilly
        6.4.1 Eli Lilly Corporation Information
        6.4.2 Eli Lilly Description and Business Overview
        6.4.3 Eli Lilly Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Eli Lilly Endocrine System Drugs Product Portfolio
        6.4.5 Eli Lilly Recent Developments/Updates
    6.5 AstraZeneca
        6.5.1 AstraZeneca Corporation Information
        6.5.2 AstraZeneca Description and Business Overview
        6.5.3 AstraZeneca Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 AstraZeneca Endocrine System Drugs Product Portfolio
        6.5.5 AstraZeneca Recent Developments/Updates
    6.6 AbbVie
        6.6.1 AbbVie Corporation Information
        6.6.2 AbbVie Description and Business Overview
        6.6.3 AbbVie Endocrine System Drugs Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 AbbVie Endocrine System Drugs Product Portfolio
        6.6.5 AbbVie Recent Developments/Updates
7 Endocrine System Drugs Manufacturing Cost Analysis
    7.1 Endocrine System Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Endocrine System Drugs
    7.4 Endocrine System Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Endocrine System Drugs Distributors List
    8.3 Endocrine System Drugs Customers
9 Endocrine System Drugs Market Dynamics
    9.1 Endocrine System Drugs Industry Trends
    9.2 Endocrine System Drugs Market Drivers
    9.3 Endocrine System Drugs Market Challenges
    9.4 Endocrine System Drugs Market Restraints
10 Global Market Forecast
    10.1 Endocrine System Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Endocrine System Drugs by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Endocrine System Drugs by Type (2023-2028)
    10.2 Endocrine System Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Endocrine System Drugs by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Endocrine System Drugs by Application (2023-2028)
    10.3 Endocrine System Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Endocrine System Drugs by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Endocrine System Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Endocrine System Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Endocrine System Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Endocrine System Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Endocrine System Drugs Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Endocrine System Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Endocrine System Drugs Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Endocrine System Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Endocrine System Drugs Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Endocrine System Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Endocrine System Drugs Manufacturing Sites and Area Served
    Table 11. Manufacturers Endocrine System Drugs Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Endocrine System Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endocrine System Drugs as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Endocrine System Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Endocrine System Drugs Sales Market Share by Region (2017-2022)
    Table 17. Global Endocrine System Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Endocrine System Drugs Revenue Market Share by Region (2017-2022)
    Table 19. North America Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Endocrine System Drugs Sales Market Share by Country (2017-2022)
    Table 21. North America Endocrine System Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Endocrine System Drugs Revenue Market Share by Country (2017-2022)
    Table 23. Europe Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Endocrine System Drugs Sales Market Share by Country (2017-2022)
    Table 25. Europe Endocrine System Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Endocrine System Drugs Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Endocrine System Drugs Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Endocrine System Drugs Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Endocrine System Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Endocrine System Drugs Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Endocrine System Drugs Sales Market Share by Country (2017-2022)
    Table 33. Latin America Endocrine System Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Endocrine System Drugs Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Endocrine System Drugs Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Endocrine System Drugs Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Endocrine System Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Endocrine System Drugs Revenue Market Share by Country (2017-2022)
    Table 39. Global Endocrine System Drugs Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Endocrine System Drugs Sales Market Share by Type (2017-2022)
    Table 41. Global Endocrine System Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Endocrine System Drugs Revenue Share by Type (2017-2022)
    Table 43. Global Endocrine System Drugs Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Endocrine System Drugs Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Endocrine System Drugs Sales Market Share by Application (2017-2022)
    Table 46. Global Endocrine System Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Endocrine System Drugs Revenue Share by Application (2017-2022)
    Table 48. Global Endocrine System Drugs Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Novo Nordisk Corporation Information
    Table 50. Novo Nordisk Description and Business Overview
    Table 51. Novo Nordisk Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Novo Nordisk Endocrine System Drugs Product
    Table 53. Novo Nordisk Recent Developments/Updates
    Table 54. Sanofi Corporation Information
    Table 55. Sanofi Description and Business Overview
    Table 56. Sanofi Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Sanofi Endocrine System Drugs Product
    Table 58. Sanofi Recent Developments/Updates
    Table 59. Merck Corporation Information
    Table 60. Merck Description and Business Overview
    Table 61. Merck Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. Merck Endocrine System Drugs Product
    Table 63. Merck Recent Developments/Updates
    Table 64. Eli Lilly Corporation Information
    Table 65. Eli Lilly Description and Business Overview
    Table 66. Eli Lilly Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Eli Lilly Endocrine System Drugs Product
    Table 68. Eli Lilly Recent Developments/Updates
    Table 69. AstraZeneca Corporation Information
    Table 70. AstraZeneca Description and Business Overview
    Table 71. AstraZeneca Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. AstraZeneca Endocrine System Drugs Product
    Table 73. AstraZeneca Recent Developments/Updates
    Table 74. AbbVie Corporation Information
    Table 75. AbbVie Description and Business Overview
    Table 76. AbbVie Endocrine System Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. AbbVie Endocrine System Drugs Product
    Table 78. AbbVie Recent Developments/Updates
    Table 79. Production Base and Market Concentration Rate of Raw Material
    Table 80. Key Suppliers of Raw Materials
    Table 81. Endocrine System Drugs Distributors List
    Table 82. Endocrine System Drugs Customers List
    Table 83. Endocrine System Drugs Market Trends
    Table 84. Endocrine System Drugs Market Drivers
    Table 85. Endocrine System Drugs Market Challenges
    Table 86. Endocrine System Drugs Market Restraints
    Table 87. Global Endocrine System Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 88. Global Endocrine System Drugs Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Endocrine System Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 90. Global Endocrine System Drugs Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Endocrine System Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 92. Global Endocrine System Drugs Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Endocrine System Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 94. Global Endocrine System Drugs Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Global Endocrine System Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 96. Global Endocrine System Drugs Sales Market Share Forecast by Region (2023-2028)
    Table 97. Global Endocrine System Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 98. Global Endocrine System Drugs Revenue Market Share Forecast by Region (2023-2028)
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Endocrine System Drugs
    Figure 2. Global Endocrine System Drugs Market Share by Type in 2021 & 2028
    Figure 3. Diabetes Drug Product Picture
    Figure 4. Human Growth Hormones Product Picture
    Figure 5. Thyroid Hormone Disorder Drugs Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Endocrine System Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Medical Center
    Figure 11. Others
    Figure 12. Global Endocrine System Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Endocrine System Drugs Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Endocrine System Drugs Sales (2017-2028) & (K Pcs)
    Figure 15. Endocrine System Drugs Sales Share by Manufacturers in 2021
    Figure 16. Global Endocrine System Drugs Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Endocrine System Drugs Players: Market Share by Revenue in 2021
    Figure 18. Endocrine System Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Endocrine System Drugs Sales Market Share by Region (2017-2022)
    Figure 20. Global Endocrine System Drugs Sales Market Share by Region in 2021
    Figure 21. Global Endocrine System Drugs Revenue Market Share by Region (2017-2022)
    Figure 22. Global Endocrine System Drugs Revenue Market Share by Region in 2021
    Figure 23. U.S. Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Taiwan Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Philippines Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Vietnam Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Mexico Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Brazil Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Argentina Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Turkey Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Saudi Arabia Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. U.A.E Endocrine System Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Sales Market Share of Endocrine System Drugs by Type (2017-2022)
    Figure 48. Manufacturing Cost Structure of Endocrine System Drugs
    Figure 49. Manufacturing Process Analysis of Endocrine System Drugs
    Figure 50. Endocrine System Drugs Industrial Chain Analysis
    Figure 51. Channels of Distribution
    Figure 52. Distributors Profiles
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novo Nordisk
Sanofi
Merck
Eli Lilly
AstraZeneca
AbbVie
Frequently Asked Questions
Endocrine System Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Endocrine System Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Endocrine System Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dehydrogenases

Market Analysis and Insights: Global Dehydrogenases Market
Due to the COVID-19 pand ... Read More